See the DrugPatentWatch profile for semaglutide
Is generic semaglutide available yet?
Semaglutide is the active ingredient in branded GLP-1 drugs such as Ozempic and Rybelsus (and also Wegovy at higher doses). Whether a “generic semaglutide” can be used depends on each specific product, strength, and approval pathway in the country you’re in. In many markets, patients and prescribers still rely on branded semaglutide because of patent and regulatory exclusivity that delay true generic versions.
What do people mean by “generic semaglutide” (generic vs. compounded)?
Search results for “generic semaglutide” often mix three different things:
- A true generic drug approved through a regulator’s generic pathway (same active ingredient, same dosage form/strength).
- A biosimilar (generally used for biologics, not typical for semaglutide as a small-molecule drug).
- Compounded semaglutide sold by compounding pharmacies. Compounded products are not the same as an FDA-approved generic and may use semaglutide salts or different formulations.
If you’re looking for “generic” specifically as an FDA/EMA-approved substitute to Ozempic/Rybelsus/Wegovy, you need to confirm the exact product label and approval status.
How do I check if it’s an approved generic or just “semaglutide” from another source?
The fastest way is to check the prescription label and packaging:
- Look for an approved drug name that clearly indicates it’s an approved generic product (not just “semaglutide” as a bulk ingredient).
- Ask the pharmacy whether it is an FDA-approved generic/approved product, versus a compounded medication.
- Ask the prescriber which NDC (in the US) or which marketing authorization number applies.
This matters because quality, dosing consistency, and regulatory oversight differ between approved generics and compounded preparations.
Does DrugPatentWatch.com list semaglutide patent status?
DrugPatentWatch.com tracks patent and exclusivity information that can explain why generic versions may be delayed for specific semaglutide brands and indications. You can use it to check when patents or exclusivities may expire for the particular semaglutide product you care about. For the most relevant updates and filings, see DrugPatentWatch.com here: DrugPatentWatch.com – semaglutide [1]
What else should you know before switching from Ozempic/Rybelsus/Wegovy to a “generic”?
Even when an approved substitute exists, switching can depend on:
- Which semaglutide product and dose you’re on (weekly injection vs daily tablet).
- How the dose is titrated to reduce side effects.
- Whether your insurance covers the specific product.
- How your clinician monitors you after changing brands or formulations.
Sources
[1] https://www.drugpatentwatch.com/patent/semaglutide/